Cargando…
Pharmacokinetics and Pharmacodynamics of Posaconazole
Posaconazole is typically used for preventing invasive yeast and mold infections such as invasive aspergillosis in high-risk immunocompromised patients. The oral suspension was the first released formulation and many pharmacokinetic and pharmacodynamic studies of this formulation have been published...
Autores principales: | Chen, Lu, Krekels, Elke H. J., Verweij, Paul. E., Buil, Jochem B., Knibbe, Catherijne A. J., Brüggemann, Roger J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183491/ https://www.ncbi.nlm.nih.gov/pubmed/32323222 http://dx.doi.org/10.1007/s40265-020-01306-y |
Ejemplares similares
-
Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
por: Wasmann, Roeland E., et al.
Publicado: (2017) -
Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy
por: Kantae, Vasudev, et al.
Publicado: (2016) -
Implications for IV posaconazole dosing in the era of obesity
por: Wasmann, Roeland E, et al.
Publicado: (2020) -
High‐dose posaconazole for azole‐resistant aspergillosis and other difficult‐to‐treat mould infections
por: Schauwvlieghe, Alexander F. A. D., et al.
Publicado: (2019) -
Quantifying the Pharmacodynamics of Morphine in the Treatment of Postoperative Pain in Preverbal Children
por: Goulooze, Sebastiaan C., et al.
Publicado: (2021)